(Total Views: 170)
Posted On: 10/02/2019 9:56:06 AM
Post# of 23609

PBIO data demonstrated the feasibility of proteogenomic characterization of known-patient tumors for specimen preparation in support of large-scale analyses in the U.S. Cancer Moonshot’s APOLLO program. This program focuses on genetic sequencing and proteomic analysis of tumors in order to develop clinically actionable molecular panels for precision medicine and personalized health. https://finance.yahoo.com/news/pressure-biosc...00015.html


Scroll down for more posts ▼